Advanced Parkinson's disease: Use of partial dopamine agonist, ciladopa

Neurology ◽  
1987 ◽  
Vol 37 (5) ◽  
pp. 863-863 ◽  
Author(s):  
A. Lieberman ◽  
G. Gopinathan ◽  
A. Neophytides ◽  
P. Pasternack ◽  
M. Goldstein
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Advanced Parkinson’S Disease ◽  
Partial Dopamine Agonist

Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease

2010 ◽  
Vol 25 (6) ◽  
pp. 738-746 ◽  
Author(s):  
Juliana Bronzova ◽  
Cristina Sampaio ◽  
Robert A. Hauser ◽  
Anthony E. Lang ◽  
Olivier Rascol ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Early Parkinson’S Disease ◽  
Partial Dopamine Agonist

Treatment of parkinson's disease with the partial dopamine agonist EMD 49980

1993 ◽  
Vol 8 (2) ◽  
pp. 195-197 ◽  
Author(s):  
Daniele Bravi ◽  
Thomas L. Davis ◽  
M. Maral Mouradian ◽  
Thomas N. Chase
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Partial Dopamine Agonist

Motor effects of the partial dopamine agonist (?)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in Parkinson's disease

1994 ◽  
Vol 9 (5) ◽  
pp. 577-581 ◽  
Author(s):  
L. Verhagen Metman ◽  
V. H. Sethy ◽  
J. R. Roberts ◽  
D. Bravi ◽  
J. I. Hoff ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Motor Effects ◽  
Partial Dopamine Agonist
Sign in / Sign up

Export Citation Format

Share Document